title: Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms.
abstract: We have previously demonstrated that one dimensional (1D) proton (1H) magnetic resonance spectroscopy (MRS) can distinguish normal thyroid tissue from thyroid carcinoma using a spectral ratio of peak intensity at 1.7 ppm/0.9 ppm. Two dimensional (2D) 1H-MRS allows identification of specific molecules that have overlapping peaks in the 1D-MR spectrum. Specimens from 93 consecutive thyroid nodules were examined using 2D 1H-MRS on a Bruker AM-360 wide-bore spectrometer. There was a progressive increase in lipid cross peaks assigned to di-/triglycerides when comparing colloid/hyperplastic nodules to follicular adenoma, and adenoma to carcinoma. A specific cross peak attributable to cholesterol/cholesteryl esters was commonly seen in carcinomas. In contrast, two unassigned cross peaks unique to the thyroid were more prevalent in benign lesions. There was an overall increase in cross peaks attributable to cell surface fucosylation in carcinoma when compared to benign lesions, although the fucose spectral pattern was not specific for cancer. On this basis, a spectral ratio of peak intensity at 2.05 ppm/0.9 ppm more clearly distinguished benign follicular adenoma from carcinoma. 2D 1H-MRS thus identifies chemical changes that allow more specific tissue characterization of thyroid neoplasms.
authors.affiliation: Institute for Magnetic Resonance Research, Blackburn Building, D06, University of Sydney, Sydney, New South Wales 2006, Australia.
authors.forename: W B
authors.initials: WB
authors.lastname: Mackinnon
authors.forename: L
authors.initials: L
authors.lastname: Delbridge
authors.forename: P
authors.initials: P
authors.lastname: Russell
authors.forename: C L
authors.initials: CL
authors.lastname: Lean
authors.forename: G L
authors.initials: GL
authors.lastname: May
authors.forename: S
authors.initials: S
authors.lastname: Doran
authors.forename: S
authors.initials: S
authors.lastname: Dowd
authors.forename: C E
authors.initials: CE
authors.lastname: Mountford
mesh_terms: D000236:Adenoma / Q000378:metabolism / Q000473:pathology; D000596:Amino Acids / Q000032:analysis; D002277:Carcinoma / Q000378:metabolism / Q000473:pathology; D002784:Cholesterol / Q000032:analysis; D002788:Cholesterol Esters / Q000032:analysis; D004075:Diglycerides / Q000032:analysis; D005643:Fucose / Q000032:analysis; D006801:Humans; D006859:Hydrogen; D006965:Hyperplasia; D007773:Lactates / Q000032:analysis; D008055:Lipids / Q000032:analysis; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D011522:Protons; D013961:Thyroid Gland / Q000737:chemistry / Q000473:pathology; D013964:Thyroid Neoplasms / Q000378:metabolism* / Q000473:pathology; D016606:Thyroid Nodule / Q000378:metabolism / Q000473:pathology; D014280:Triglycerides / Q000032:analysis
chemical_list: D000596:Amino Acids; D002788:Cholesterol Esters; D004075:Diglycerides; D007773:Lactates; D008055:Lipids; D011522:Protons; D014280:Triglycerides; D005643:Fucose; D006859:Hydrogen; D002784:Cholesterol